| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/27/2010 | CN101632663A Novel molecular target for neurotoxicity |
| 01/27/2010 | CN100585396C PCR detection method for vibrio fluvailis in food |
| 01/27/2010 | CN100585395C PCR detection method for vibrio vulnificus and vibrio alginolyticus in food |
| 01/27/2010 | CN100585394C PCR detection method for vibrio cholerae, vibrio parahaemolyticus, and vibrio mimicus in food |
| 01/27/2010 | CN100585388C Method for detecting bacillus tubercle by adopting double-color flow cytometry |
| 01/27/2010 | CN100584958C Method for obtaining molecular marker for identifying three line hybrid rice maintainer line character |
| 01/27/2010 | CN100584957C Use of a type III restriction enzyme to isolate identification tags comprising more than 25 nucleotides |
| 01/27/2010 | CN100584956C Reagent kit and process for detecting river vibrio in loop mediated constant temperature amplification method |
| 01/27/2010 | CN100584948C Procine circoviruses, vaccines and diagnostic reagents |
| 01/27/2010 | CN100584947C Nucleotide sequence with internal ribosome entry site (IRES) effect |
| 01/27/2010 | CN100584945C Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 01/27/2010 | CN100584273C Optical glucose sensor chip and method of manufacturing the same |
| 01/26/2010 | US7653492 Method of reducing the effect of direct interference current in an electrochemical test strip |
| 01/26/2010 | US7653491 Computer systems and methods for subdividing a complex disease into component diseases |
| 01/26/2010 | US7651857 Inhibiting antigen presentation, comprising the step of supplying to an antigen-presenting cell, such as a dendritic cell, or precursor cell, a modulator, preferably an enhancer, of Toll-related receptor signalling |
| 01/26/2010 | US7651849 Increased activity and stability at increased pH and temperature |
| 01/26/2010 | US7651847 Methods of oligosaccharide profiling for the detection of cancer |
| 01/26/2010 | US7651846 Treatment and diagnosis of conditions associated with elevated arginase activity |
| 01/26/2010 | US7651845 Combined control of insulin bolus dosing and basal delivery for the goal of achieving normal glycemic response to meals, exercise, stressors, and other perturbations to blood glucose levels |
| 01/26/2010 | US7651844 Method for screening agents capable of treating obesity |
| 01/26/2010 | US7651842 Imunogenic complex comprising ribosomes |
| 01/26/2010 | US7651841 High throughput assay for visual and quantitative measurement and detection of particles in sample; immunoassays |
| 01/26/2010 | US7651840 Detecting single nucleotide polymorphism ; kits; drug screening; neurodegenerative disease |
| 01/26/2010 | US7651839 Method of optimizing amplification in PCR |
| 01/26/2010 | US7651838 diagnosis on isolated non-apoptotic epithelial foetal cells of maternal blood after they have been enriched by filtration, morphologically or immunologically and genetically analysed; non-invasive; accurate genotype; determining genetic sex of the foetus; perfectly harmless for the mother and the foetus |
| 01/26/2010 | US7651837 Method for detecting and identifying microorganism causative of infection |
| 01/26/2010 | US7650804 Mechanochemical sensor |
| 01/26/2010 | CA2559181C A method of evaluating freshness of a fish product |
| 01/26/2010 | CA2443320C Separation of target material using affinity substance containing labelled nucleic acid chain by electrophoresis |
| 01/26/2010 | CA2429682C Device for thermal cycling |
| 01/26/2010 | CA2421588C Tnf receptor-like molecules and uses thereof |
| 01/26/2010 | CA2419490C Functional protein arrays |
| 01/26/2010 | CA2322780C Detection of fermentation-related microorganisms |
| 01/26/2010 | CA2298994C Electrochemical system for determining blood coagulation time |
| 01/26/2010 | CA2256773C System and process for carrying out and monitoring polymerase chain reaction |
| 01/26/2010 | CA2216630C Cell line and processes for replicating rabies viruses and detecting them quantitatively |
| 01/26/2010 | CA2213301C Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm) |
| 01/26/2010 | CA2159043C Method of quantitating genomic dna |
| 01/21/2010 | WO2010009440A2 Non-invasive fetal rhd genotyping from maternal whole blood |
| 01/21/2010 | WO2010009426A2 Devices and methods for reagent delivery |
| 01/21/2010 | WO2010009415A1 Methods and systems for microfluidic dna sample preparation |
| 01/21/2010 | WO2010009404A2 Markers associated with soybean rust resistance and methods of use therefor |
| 01/21/2010 | WO2010009398A1 Methods for pcr-based detection of "ultra short" nucleic acid sequences |
| 01/21/2010 | WO2010009377A2 Methods and compositions for pharmacogenetic analysis of anti-inflammatory drugs in the treatment of rheumatoid arthritis and other inflammatory diseases |
| 01/21/2010 | WO2010009368A2 Compositions for the detection and treatment of colorectal cancer |
| 01/21/2010 | WO2010009337A2 Signatures and pcdeterminants associated with prostate cancer and methods of use thereof |
| 01/21/2010 | WO2010009203A2 Lateral flow nucleic acid detector |
| 01/21/2010 | WO2010009190A1 Methods of treating atherosclerosis |
| 01/21/2010 | WO2010009121A2 Colon stem cells associated with colitis and colorectal cancer and methods of use |
| 01/21/2010 | WO2010009105A1 Resonant sensor capable of wireless interrogation |
| 01/21/2010 | WO2010009074A2 Method for predicting and detecting tumor metastasis |
| 01/21/2010 | WO2010009060A2 Molecular beacon-based methods for detection of targets using abscription |
| 01/21/2010 | WO2010008895A2 Per3 as a biomarker for prognosis of er-positive breast cancer |
| 01/21/2010 | WO2010008870A1 Small angle light scattering assay system and method for detecting malaria infection |
| 01/21/2010 | WO2010008862A2 Live attenuated catfish vaccine and method of making |
| 01/21/2010 | WO2010008858A1 Use of iron-related pathways and genes for treatment and diagnosis of parkinson's disease |
| 01/21/2010 | WO2010008838A2 Kinase substrates |
| 01/21/2010 | WO2010008809A2 Compositions and methods for early stage sex determination |
| 01/21/2010 | WO2010008588A2 Modulation of gm98 (mrf) in remyelination |
| 01/21/2010 | WO2010008543A2 Molecular signatures for diagnosing scleroderma |
| 01/21/2010 | WO2010008480A2 Methods and apparatus for measuring analytes using large scale fet arrays |
| 01/21/2010 | WO2010008463A1 Deficiency in the histone demethylase jhdm2a results in impaired energy expenditure and obesity |
| 01/21/2010 | WO2010008427A1 Tryptophan catabolism in cancer treatment and diagnosis |
| 01/21/2010 | WO2010008084A1 Novel use application of sugar chain-recognizing receptor |
| 01/21/2010 | WO2010008071A1 Method for screening of gene mutation by utilizing quantification technique |
| 01/21/2010 | WO2010008001A1 Aptamer against il-17 and use thereof |
| 01/21/2010 | WO2010007701A1 Therapeutic agent and test agent for disease with myocardial necrosis |
| 01/21/2010 | WO2010007605A1 A method of assessing bacterial load of a sample |
| 01/21/2010 | WO2010007531A2 Use of defensin alpha 1 and/or defensin alpha 4, as a marker for predicting treatment response and/or a relapse in a patient suffering from chronic myeloid leukaemia |
| 01/21/2010 | WO2010007464A1 USE OF DEFENSIN α1 AND/OR DEFENSIN α4, AS A MARKER FOR PREDICTING A RELAPSE IN A PATIENT SUFFERING FROM CHRONIC MYELOID LEUKAEMIA |
| 01/21/2010 | WO2010007391A2 Hexacyanoferrate modified electrode |
| 01/21/2010 | WO2010007355A1 Nucleic acid amplification |
| 01/21/2010 | WO2010007255A2 Method for purifying nucleic acids from microorganisms present in liquid samples |
| 01/21/2010 | WO2010007214A1 Enzymatical modif ication of cell glycosylation using serum albumin and divalent cations |
| 01/21/2010 | WO2010007140A1 Method for in vitro assay of the circulating tissue factor, and use in the detection of coagulation diseases |
| 01/21/2010 | WO2010007132A1 Methods and kit for analyte detection |
| 01/21/2010 | WO2010007118A1 Method for cell identification and cell sorting |
| 01/21/2010 | WO2010007093A1 A method for lung cancer early detection and prognosis |
| 01/21/2010 | WO2010007083A2 Methods and nucleic acids for analyses of cell proliferative disorders |
| 01/21/2010 | WO2010007063A2 Method of diagnosing dyslexia |
| 01/21/2010 | WO2010006814A1 Method for determining the origin of a sample |
| 01/21/2010 | WO2010006732A2 Brassica plant comprising a mutant indehiscent allelle |
| 01/21/2010 | WO2010006605A2 Thrombin substrate and assay for determining the level of bioactive thrombin in a sample |
| 01/21/2010 | WO2010006552A1 The dna sequencing reaction unit, platform and system |
| 01/21/2010 | WO2010006482A1 A multipurpose micro electric field networking cell processing device |
| 01/21/2010 | WO2010006415A1 Mammalian cell expression vectors and utilization |
| 01/21/2010 | WO2010006414A1 Methods, kits and compositions for determining severity and survival of heart failure in a subject |
| 01/21/2010 | WO2010006373A1 High fructan cereal plants |
| 01/21/2010 | WO2009146036A3 Quantification of differences between measured values and statistical validation based on the differences |
| 01/21/2010 | WO2009145836A3 Methods and devices based upon a novel form of nucleic acid duplex on a surface |
| 01/21/2010 | WO2009140375A3 Phage-mediated bioluminescent detection of yersinia pestis |
| 01/21/2010 | WO2009137836A3 Cell potency assay |
| 01/21/2010 | WO2009134418A3 Assay for identifying agents that modulate epigenetic silencing, and agents identified thereby |
| 01/21/2010 | WO2009131366A3 Cdca5 as a diagnosis marker and therapeutic agent for gastric cancer or colorectal cancer |
| 01/21/2010 | WO2009131365A3 Cst1, dcc1, ifitm1 or melk as markers for diagnosing stomach cancer |
| 01/21/2010 | WO2009129397A3 High throughput dispenser |
| 01/21/2010 | WO2009128644A3 Genome-scale butanol-producing microorganism metabolic network model and methods using the same for analysis of metabolic characteristics of butanol-producing microorganisms and for screening deletion targets |
| 01/21/2010 | WO2009128056A3 A method for screening compounds comprising the use of picornavirus protease 2a |
| 01/21/2010 | WO2009126650A3 Inhibition of angiognesis |
| 01/21/2010 | WO2009126343A3 Oil emulsions and methods for manufacture and use thereof |